Virox Technologies Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Virox Technologies Inc. - overview
Established
1998
Location
Oakville, ON, Canada
Primary Industry
Pharmaceuticals
About
Virox Technologies Inc. focuses on developing eco-friendly disinfectants that ensure safety and effectiveness across various sectors, particularly in healthcare and agriculture. Founded in 1998, Virox Technologies Inc. is headquartered in Oakville, Canada, and specializes in environmentally conscious disinfection solutions.
The company was established by a team of experts in the field of cleaning and sanitation, aiming to provide effective products for human and animal health. The CEO, Randy Pilon, has extensive experience in the technology and sanitation industry, contributing to the company’s innovative approach. Virox operates globally, distributing its products in over 70 countries, including major markets in North America, Europe, and Asia. Virox Technologies Inc.
specializes in the development and manufacturing of eco-conscious disinfectants that prioritize safety, efficacy, and sustainability. Their core product line includes Accelerated Hydrogen Peroxide® (AHP®) and the newly introduced Citr-IQ™, both of which leverage patented antimicrobial technologies to provide effective disinfection solutions across various sectors. These products serve a diverse clientele that ranges from healthcare facilities to agricultural environments, addressing critical needs in human and animal health sectors. Virox products are formulated to meet rigorous standards of performance while being marketed as greener alternatives to traditional disinfectants.
The company has established a global presence, with its innovations available in over 70 countries, including key markets in North America, Europe, and Asia. Virox Technologies Inc. generates revenue through business-to-business transactions, primarily involving direct sales to healthcare providers, veterinary service providers, and industrial clients seeking high-quality disinfection solutions. Their flagship products, such as AHP® and Citr-IQ™, are sold as standalone offerings or integrated into comprehensive sanitation programs, promoting long-term partnerships with clients.
Virox operates on a pricing structure that often includes bulk purchasing agreements and custom service contracts, tailored to the specific needs of their clients. This transactional model enables clients to access innovative disinfectant solutions while ensuring consistent supply and support. The company's commitment to sustainability and innovation positions it favorably within the growing market for environmentally friendly cleaning products.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.virox.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Virox Technologies Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | AHP Intellectual Property | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.